Florida Society of Clinical Oncology
The Voice of Oncology in Florida
Menu
Flasco Patient Portal
Become a Member
FLASCO Meetings
Search the Florida Society of Clinical Oncology Website
SEARCH
Menu
Home
About
Profile & Mission
History
Board of Directors & Liaisons
Committees
A Year in Review
FLASCO Staff
FLASCO Oncology Captains
Membership
Benefits
Become a Member
Become a Corporate Partner
Professional Partnership Program
Corporate Partners
Events
Calendar of Events
FLASCO Events
Events
Webinars
Past Events
Advocacy
Find Your Legislator
News & Updates
Administrator Network Updates
Clinical Trials
Drugs
FLASCO News
FLASCO eNewsletter
Legislative Updates
Member Publications
For Professionals
Professional Associations
Resources
Podcasts
Job Board
Contact
FDA approves new indication for Gilotrif® in EGFR mutation-positive NSCLC
Amanda Bridges
January 18, 2018
Drugs
,
News
© 2021 FLASCO |
Premium Website Design
by
The HDG
FLASCO
Home
About
Profile & Mission
History
Board of Directors & Liaisons
Committees
A Year in Review
FLASCO Staff
FLASCO Oncology Captains
Back
Membership
Benefits
Become a Member
Become a Corporate Partner
Professional Partnership Program
Corporate Partners
Back
Events
Calendar of Events
FLASCO Events
Events
Webinars
Past Events
Back
Advocacy
Find Your Legislator
Back
News & Updates
Administrator Network Updates
Clinical Trials
Drugs
FLASCO News
FLASCO eNewsletter
Legislative Updates
Member Publications
Back
For Professionals
Professional Associations
Resources
Podcasts
Job Board
Back
Contact
Flasco Patient Portal
Become a Member
FLASCO Meetings
× Close Panel
